Radiotherapie der endokrinen Orbitopathie – State of the Art und Literaturübersicht

Kuhnt, 2004, Radiotherapy for Graves’ ophthalmopahty, Klin Monatsbl Augenh, 221, 915, 10.1055/s-2004-813774 Mourits, 2000, Radiotherapy for Graves’ orbitopathy: randomised placebo-controlled study, Lancet, 355, 1505, 10.1016/S0140-6736(00)02165-6 Werner, 1977, Modification of the classification of the eye changes of Graves’ disease: recommendations of the Ad Hoc Committee of the American Thyroid Association, J Clin Endocrinol Metab, 44, 203, 10.1210/jcem-44-1-203 Bartalena, 1983, Orbital cobalt irradiation combined with systemic corticosteroids for Graves’ ophthalmopathy: comparison with systemic corticosteroids alone, J Clin Endocrinol Metab, 56, 1139, 10.1210/jcem-56-6-1139 Bartalena, 2000, Management of Graves’ ophthalmopathy: reality and perspectives, Endocr Rev, 21, 168, 10.1210/er.21.2.168 Rödel, 2002, Functional and molecular aspects of anti-inflammatory effects of low-dose radiotherapy, Strahlenther Onkol, 178, 1 Trott, 1999, Radiobiological mechanisms of anti-inflammatory radiotherapy, Radiother Oncol, 51, 197, 10.1016/S0167-8140(99)00066-3 Mourits, 1989, Clinical criteria for the assessment of disease activity in Graves’ ophthalmopathy: a novel approach, Br J Ophthalmol, 73, 639, 10.1136/bjo.73.8.639 Behbehani, 2004, Orbital radiotherapy for thyroid-related orbitopathy, Curr Opin Ophthalmol, 16, 479, 10.1097/01.icu.0000144388.89867.03 Seegenschmiedt, 1998, Endokrine Orbitopathie: Vergleich der Langzeitergebnisse und Klassifikationen nach Radiotherapie, Strahlenther Onkol, 174, 449, 10.1007/BF03038622 Gripp, 2000, Konventionelle und virtuelle Simulation bei der Retrobulbärbestrahlung, Strahlenther Onkol, 176, 131, 10.1007/PL00002338 Heyd, 2003, German cooperative Group on Radiotherapy for Benign Diseases (GCG-BD). Radiotherapy for Graves’ orbitopathy: results of a national survey, Strahlenther Onkol, 179, 372, 10.1007/s00066-003-0911-9 Seegenchmiedt, 2000, Radiation therapy for benign diseases: patterns of care study in Germany, Int J Radiat Oncol Biol Phys, 47, 195, 10.1016/S0360-3016(99)00537-4 Kahaly, 2000, Low-versus high-dose radiotherapy for Graves’ ophthalmopathy: a randomized, single blind trial, J Clin Endocrinol Metab, 85, 102, 10.1210/jc.85.1.102 Gerling, 2003, Retrobulbar irradiation for thyroid-associated orbitopathy: double-blind compartison between 2.4 and 16Gy, Int J Radiat Oncol Biol Phys, 55, 182, 10.1016/S0360-3016(02)03795-1 Gorman, 2001, A prospective, randomized, double-blind, placebo-controlled study of orbital radiotherapy for Graves’ ophthalmopathy, Ophthalmology, 108, 1523, 10.1016/S0161-6420(01)00632-7 Prummel, 2004, A randomized controlled trial of orbital radiotherapy versus sham irradiation in patients with mild Graves’ ophthalmopathy, J Clin Endocrinol Metab, 89, 15, 10.1210/jc.2003-030809 Prummel, 1993, Randomized double-blind trial of prednisone versus radiotherapy in Graves’ ophthalmopathy, Lancet, 342, 949, 10.1016/0140-6736(93)92001-A Götz, 2001, Conformal irradiation technique for the peri- and retrobulbar space in endocrine orbitopathy, Z Med Phys, 11, 201, 10.1016/S0939-3889(15)70514-3 Akmansu, 2003, The risk of radiation induced carinogenesis after external beam radiotherapy of Graves’ orbitopathy, Ophthalmic Res, 35, 150, 10.1159/000070050 Broerse, 1999, Assesment of a carcinogenic risk for treatment of Graves’ ophthalmopathy in dependence on age and irradiation geometry, Radiother Oncol, 53, 205, 10.1016/S0167-8140(99)00118-8 Esser, 1988, Quantitative Ergebnisse nach konsekutiver Corticoid- und Radiotherapie bei endokriner Ophthalmopathie, Fortschr Ophthalmol, 85, 323 Esser, 1995, Corticoid- und Strahlentherapie bei endokriner Orbitopathie, Nuklearmed, 18, 163 Feyerabend, 1989, Die Rolle der Strahlentherapie bei der endokrinen Orbitopathie, Klin Monatsbl Augenheilk, 195, 1, 10.1055/s-2008-1046403 Friedrich, 1997, Clinical importance of radiotherapy in the treatment of Graves’ Disease, vol. 30, 206 Fritsch, 1981, Ergebnisse der Retrobulbärbestrahlung bei benigner endokriner Ophthalmopathie, Strahlentherapie, 157, 305 Grauthoff, 1980, Strahlentherapie der endokrinen Orbitopathie, Strahlentherapie, 156, 226 Heinze, 1974, Strahlentherapie der endokrinen Ophthalmopathie mit 18MeV-Bremsstrahlung, Strahlentherapie, 148, 226 Horster, 1983, Endokrine Orbitopathie, Deut Med Wochenschr, 108, 413, 10.1055/s-2008-1069569 Hurbli, 1985, Radiation therapy for thyroid eye diseases, Am J Ophthalmol, 99, 633, 10.1016/S0002-9394(14)76027-1 Pfluger, 1990, Retrobulbärbestrahlung bei endokriner Ophthalmopathie: Vergleich zwischen 10 und 16Gy Herddosis, Strahlenther Onkol, 166, 673 Staar, 1997, Results and prognostic factors in retrobulbar radiotherapy combined with systemic corticosteroids for endocrine orbitopathy (Graves’ Disease), vol. 30, 206 Uhlenbrock, 1984, Strahlentherapie der endokrinen Ophthalmopathie – Auswertung von 56 Fällen, Strahlentherapie, 160, 485 Wildmeister, 1972, Zur Therapie der endokrinen Ophthalmopathie, Deut Med Wochenschr, 97, 1708, 10.1055/s-0028-1107636 Bartalena, 1988, Orbital irradiation in the treatment of Graves’ ophthalmopathy, Bull Soc Belge Ophthalmol, 226, 71 Donaldson, 1973, Supervoltage orbital radiotherapy for Graves’ ophthalmopathy, J Clin Endocrinol Metab, 37, 276, 10.1210/jcem-37-2-276 Friedrich, 1997, Clinical importance of radiotherapy in the treatment of Graves’ Disease, vol. 30, 206 Kriss, 1983, Graves’ ophthalmopathy, 104 Kriss, 1989, Supervoltage orbital radiotherapy for pro-gressive Graves’ ophthalmopathy: results of a twenty year experience, Acta Endocrinol (Copenh), 121, 154 Lloyd, 1992, Supervoltage orbital radiotherapy in 36 cases of Graves’ disease, Am J Ophthalmol, 113, 374, 10.1016/S0002-9394(14)76158-6 Marcocci, 1987, Orbital cobalt irradiation combined with retrobulbar or systematic cortico-steroids for Graves’ ophthalmopathy: a comparative study, Clin Endocrinol, 27, 33, 10.1111/j.1365-2265.1987.tb00836.x Marcocci, 1991, Role of orbital radiotherapy in the treatment of Graves’ ophthalmopathy, Exp Clin Endocrinol, 97, 332, 10.1055/s-0029-1211088 Petersen, 1990, Prognostic factors in the radiotherapy of Graves’ ophthalmopathy, Int J Radiat Oncol Biol Phys, 19, 259, 10.1016/0360-3016(90)90532-O Olivotto, 1985, Supervoltage radiotherapy for Graves’ ophthalmopathy: CCABC technique and results, Int J Radiat Oncol Biol Phys, 11, 2085, 10.1016/0360-3016(85)90088-4 Sandler, 1989, Results of radiotherapy for thyroid ophthalmopathy, Int J Radiat Oncol Biol Phys, 17, 823, 10.1016/0360-3016(89)90073-4 Seegenschmiedt, 1995, Megavoltage radiotherapy for severe and refractory progressive Graves’ ophthalmopathy : comparison of scoring systems and long-term results, Int J Radiat Oncol Biol Phys, 32, 286, 10.1016/0360-3016(95)97952-W Seegenschmiedt, 1998, Radiotherapie bei progredienter endokriner Orbitopathie: Langzeitresultate und Klassifikationen im Vergleich, Strahlenther Onkol, 174, 449, 10.1007/BF03038622 Konishi, 1986, Clinical evaluation of radiotherapy for Graves’ ophthalmopathy, Endocrinol Jpn, 33, 637, 10.1507/endocrj1954.33.637 Lloyd, 1992, Supervoltage orbital radiotherapy in 36 cases of Graves’ disease, Am J Ophthalmol, 113, 374, 10.1016/S0002-9394(14)76158-6 van Ouwerkerk, 1985, Radiotherapy of severe ophthalmic Graves’ disease, J Endocrinol Invest, 8, 241, 10.1007/BF03348485 Palmer, 1987, Radiation therapy for Graves ophthalmopathy: retrospective analysis, Int J Radiat Oncol Biol Phys, 13, 1815, 10.1016/0360-3016(87)90346-4 Petersen, 1990, Prognostic factors in the radiotherapy of Graves’ ophthalmopathy, Int J Radiat Oncol Biol Phys, 19, 259, 10.1016/0360-3016(90)90532-O Pigeon, 1987, High voltage orbital radiotherapy and surgical orbital decompression in the management of Graves’ ophthalmopathy, Horm Res, 26, 172, 10.1159/000180697 Ravin, 1975, Orbital radiation for the ocular changes of Graves’ disease, Am J Ophthalmol, 79, 285, 10.1016/0002-9394(75)90083-5 Teng, 1980, An evaluation of supervoltage orbital irradiation for Graves’ ophthalmopathy, Clin Endocrinol (Oxf), 13, 545, 10.1111/j.1365-2265.1980.tb03422.x Wilson, 1995, Radiotherapy for thyroid orbitopathy, Arch Ophthalmol, 113, 1420, 10.1001/archopht.1995.01100110080029